Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data.

Simbrich, Alexandra; Thibaut, Jasmine; Khil, Laura; Berger, Klaus; Riedel, Oliver; Schmedt, Niklas

Simbrich, Alexandra; Thibaut, Jasmine; Khil, Laura; Berger, Klaus; Riedel, Oliver; Schmedt, Niklas.

Afiliación

Simbrich A; Institute of Epidemiology and Social Medicine, University of Münster, 48149 Münster, Germany.
Thibaut J; Institute of Epidemiology and Social Medicine, University of Münster, 48149 Münster, Germany.
Khil L; Institute of Epidemiology and Social Medicine, University of Münster, 48149 Münster, Germany.
Berger K; Cancer Registry North Rhine-Westphalia, 44801, Bochum, Germany.
Riedel O; Institute of Epidemiology and Social Medicine, University of Münster, 48149 Münster, Germany.
Schmedt N; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, 28359 Bremen, Germany.

Neuropsychiatr Dis Treat ; 15: 1439-1457, 2019.

Article en En | MEDLINE | ID: mdl-31213818

Palabras clave

adverse events; claims data; disease-modifying drugs; drug-use patterns; multiple sclerosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Neuropsychiatr Dis Treat Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google